Barry Callebaut, Sanofi, UBS: European Equity Preview

The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index fell 1.2 percent to 265.49. The Stoxx 50 Index decreased 1.1 percent to 2,494.61. The Euro Stoxx 50 Index, a benchmark measure for nations using the euro, declined 1.5 percent to 2,530.22.

Barry Callebaut AG (BARN SW): The world’s largest maker of bulk chocolates will invest $43.4 million over the next 10 years in west and central Africa and in Indonesia to improve the quality of cocoa beans, Fraternité Matin reported, without saying where it got the information. The shares decreased 1.4 percent to 882.5 Swiss francs.

Castellum AB (CAST SS): The Swedish real estate company elected Charlotte Stroemberg as chairman of the board following Jan Kvarnstroem’s decision to resign from the post. The shares fell 1.2 percent to 87.75 kronor.

Sanofi (SAN FP): France’s biggest drugmaker lost an appeals court ruling on its patent-infringement claims against Roche Holding AG’s (ROG VX) Genentech and Biogen Idec Inc. (BIIB US) for the cancer drugs Rituxan and Avastin. Sanofi dropped 1 percent to 58.16 euros. Roche fell 0.9 percent to 158.60 Swiss francs.

UBS AG (UBSN VX): The Swiss bank hired Andrea Orcel, a top Bank of America Corp. dealmaker, as co-head of its investment bank to help revive a division rocked by key departures and last year’s $2.3 billion loss from unauthorized trading. The shares declined 0.5 percent to 12.92 Swiss francs.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE